Age and Severity of Mucosal Lesions Influence the Performance of Serologic Markers in Helicobacter pylori–Associated Gastroduodenal Pathologies
Open Access
- 1 September 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (9), 2498-2504
- https://doi.org/10.1158/1055-9965.epi-08-0289
Abstract
Objective: The course of Helicobacter pylori infection and antibody response to CagA in patients with preneoplastic lesions and gastric cancer has not been thoroughly studied. We aimed to study H. pylori infection and antibody response to CagA in patients with non–atrophic gastritis, preneoplastic lesions, and gastric cancer. Methods: We studied patients attending one Oncology Hospital and one General Hospital in Mexico City. Diagnosis was based on endoscopy and histopathology in biopsies from six stomach regions. H. pylori infection was assessed by histology and serology, and antibodies against CagA were measured with immunoassay. Results: We included 618 patients, 368 with non–atrophic gastritis, 126 with precancerous lesions, and 65 with gastric cancer; in addition, 59 patients with duodenal ulcer were studied. Detection of infection and IgG against CagA had a significant increase from non–atrophic gastritis to mild and up to advanced stages of metaplasia (P < 0.05), followed by decreased infection and IgG to CagA in patients with gastric cancer (P < 0.05). However, infection and CagA antibodies were associated with young gastric cancer cases. Duodenal ulcer showed a significant association with infection detected by histology and serology, particularly among women, and a trend to associate with IgG to CagA. Conclusions: This study shows that H. pylori infection and CagA are risk markers for intestinal metaplasia. The prevalence of these risk markers decreases in gastric cancer, probably reflecting that infection decreases after advanced atrophy and metaplasia in the gastric mucosa. State of the disease, age, and sex influence the association of H. pylori infection and IgG response to CagA with gastroduodenal diseases. (Cancer Epidemiol Biomarkers Prev 2008;17(9):2498–504)Keywords
This publication has 29 references indexed in Scilit:
- Helicobacter pylori Cytotoxin-Associated Genotype and Gastric Precancerous LesionsJNCI Journal of the National Cancer Institute, 2007
- Gastric Cancer is Related to Early Helicobacter pylori Infection in a High-Prevalence CountryCancer Epidemiology, Biomarkers & Prevention, 2007
- The Detection, Surveillance and Treatment of Premalignant Gastric Lesions Related to Helicobacter pylori InfectionHelicobacter, 2007
- Trends in Helicobacter pylori Infection and Gastric Cancer in MexicoCancer Epidemiology, Biomarkers & Prevention, 2005
- Specific Serum Immunoglobulin G Response to Urease and CagA Antigens of Helicobacter pylori in Infected Children and Adults in a Country with High Prevalence of InfectionClinical and Vaccine Immunology, 2002
- Epidemiologic Panorama of Stomach Cancer Mortality in MexicoArchives of Medical Research, 2001
- Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsiaJournal of Clinical Pathology, 2001
- Helicobacter pylorivacAandcagAGenotypes in Mexican Adults and ChildrenThe Journal of Infectious Diseases, 2000
- Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in JapanJapanese Journal of Cancer Research, 1995
- Helicobacter pylori: the link with gastric cancerEuropean Journal Of Cancer Prevention, 1994